Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 40 (32) 3709-3718
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
12
Parents:
3740  
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171, UG1CA233180, UG1CA233327, UG1CA233331, T32 CA092203, P50 CA206963, R35 CA197734, UG1CA233338  
Corr. Author:
 
Authors:
                         
Networks:
LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-OH007, OH070   
Study
Alliance-A152118
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-10001, Alliance-A152023, CALGB-10102, CALGB-10201, CALGB-10403, CALGB-10502, CALGB-10603, CALGB-10701, CALGB-10801, CALGB-11001, CALGB-11002, CALGB-19801, CALGB-19802, CALGB-9720, CALGB-19808, CALGB-8461, CALGB-9665
Phases:
N/A, 1/2, 2, 3, N/A
Keywords:
ORIGINAL REPORTS, Hematologic Malignancy